About Atlas Accelerator
Atlas Accelerator, an accelerator and incubator program founded in 1996, is based in Bellevue, United States. With a presence in 4 countries, it has supported around 102 startups in sectors like Enterprise Applications, Consumer. As of Oct 2026, Atlas Accelerator has witnessed 34 portfolio exits. Most notable companies in
its portfolio include Zipcar, AppFolio and Evri. The program is backed by a team of 4 people who primarily support Seed startups based in United States. Its latest investment was a $600K Angel round in Booktrope on Dec 2013, which also saw participation from Alliance of Angels and Seattle Angel Conference.
Key Metrics
Founded Year
1996
Location
Bellevue, United States
Sectors of Investment
Stages of Investment
Seed & Angel
Locations of Investment
Atlas Accelerator's List of Top Investments
Atlas Accelerator has a portfolio of 102 companies. Their most notable investmentis in EscapiaTheir portfolio spans across United States, Canada, Turkey and 1 more locations. They have invested in Enterprise Applications, Consumer, Life Sciences and 24 other sectors, across stages such as Seed, Angel stages. Here is the list of top investments by Atlas Accelerator:1. Zipcar
Operator of a network providing on-demand access to shared vehicles. The service allows members to reserve vehicles for short periods. Included are standard damage protection, maintenance, and support. The program offers options for both personal and business use.
Key facts about Zipcar
- Founded Year: 2000
- Location: Boston (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2012
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $60.7M
- Employee Count: 398 as on Sep 30, 2026
- Investors: Meritech, Greenline and 11 Others
- Latest Funding Round: Series G, Dec 15, 2010, $*****
- Highlight: Acquired
2. AppFolio
SaaS-driven property management software for owners and residential property managers. Features include owner communication, resident communication, board member communication and management, built-in marketing tools, lease management, online maintenance, reporting, online payments, utility management, debt collection, custom training, onboarding, support work orders, and accounting.
Key facts about AppFolio
- Founded Year: 2006
- Location: Santa Barbara (United States)
- Annual Revenue: $500M - $1B as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $30M
- Employee Count: 1,807 as on Sep 30, 2026
- Investors: Entrada Ventures, Lagfe and 4 Others
- Latest Funding Round: Series B, Aug 18, 2009, $*****
- Highlight: Public
3. Evri
App-based platform offering door-to-door courier delivery services. It offers parcel and courier delivery services for documents, and bulk parcels. The app helps users to send, recieve and track parcels. The app is available on the Android and iOS platform.
Key facts about Evri
- Founded Year: 1974
- Location: Leeds (United Kingdom)
- Stage: Acquired
- Total Funding till date: $349K
- Employee Count: 13,344 as on Sep 30, 2026
- Investors: Advent International, Osprey Investors and 1 Other
- Latest Funding Round: Unattributed, Feb 19, 2025, $*****
- Highlight: Acquired
Online B2B e-distributor of electronic components. The company offers interconnect, passives, test and measurement products, sensors, semiconductors, electromechanical parts, lighting solutions, wireless components, and more. The platform mainly offers products to multiple industries like medical equipment, transportation, military/aerospace, automotive, communications, energy/renewable energy, industrial, and research and development industries.
Key facts about Digi-Key Electronics
- Founded Year: 1972
- Location: Thief River Falls (United States)
- Annual Revenue: $1B+ as on Oct 31, 2025
- Stage: Funding Raised
- Employee Count: 2,689 as on Sep 30, 2026
- Investors: Atlas Accelerator
- Highlight: Editors' Pick
5. Napo Pharma
Napo Pharmaceuticals develops and commercializes small molecule therapeutics for international markets. It has one approved product in the market: Crofelemer, primarily indicated for diarrhea associated with HIV/AIDS. Crofelmer has been licensed to Glenmark and Salix Pharma. Other candidates include products for insulin-resistant diseases, diarrhea-predominant IBS, acute infectious diarrhea and pediatric diarrhea.
Key facts about Napo Pharma
- Founded Year: 2001
- Location: San Francisco (United States)
- Stage: Acquired
- Total Funding till date: $5.14M
- Employee Count: 12 as on Sep 30, 2026
- Investors: Kingdon Capital Management, BioVeda China Fund and 3 Others
- Latest Funding Round: Post IPO, Jan 03, 2017, $*****
- Highlight: Acquired
Atlas Accelerator's Investments by Stage
Atlas Accelerator has made 2 investments in Seed stage with an average round size of $1.6M and 1 investment in Angel stage with an average round size of $600K.Stage of entry | No. of Investments |
|---|---|
Seed | 2 |
Angel | 1 |
Note: We have considered here, only first round of investments
Atlas Accelerator's Investments by Sector
Atlas Accelerator has a diverse portfolio, with companies operating in the Enterprise Applications, Media & Entertainment and Travel and Hospitality Tech. Notably, it has invested in 59 Tech companies, 54 Enterprise (B2B) companies, 42 Software companies and at least 29 companies focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 2 |
Media & Entertainment | 1 |
Travel and Hospitality Tech | 1 |
Note: We have considered here, only first round of investments
Atlas Accelerator's Investments by Geography
Atlas Accelerator has made most investments in United States (3).Atlas Accelerator's recent investments
Atlas Accelerator has not made any investment in 2026 so far.Here are the most recent investments by Atlas Accelerator:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Dec 2013 | United States | Angel | 5717 | [+1] | |
Aug 26, 2009 | United States | Seed | 4958 | ||
Jun 24, 2009 | United States | Seed | 7494 |
IPOs and Publicly Listed companies in Atlas Accelerator's Portfolio
4 of Atlas Accelerator's portfolio companies have become public. Impel NeuroPharma got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Apr 2021 at marketcap of $291M and AppFolio got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ).Here are Atlas Accelerator's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 23, 2021 | - | - | 2308 | |
Jun 26, 2015 | - | - | 9373 | |
Apr 07, 2014 | - | - | 4647 | |
Sep 30, 2004 | - | - | 1781 |
Acquired companies in Atlas Accelerator's Portfolio
30 companies from Atlas Accelerator's portfolio have been acquired. The most recent acquisition was Intersect in Dec 2025 by Alphabet for $*****.Here are Atlas Accelerator's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 22, 2025 | - | - | 9760 | |
Oct 16, 2025 | - | - | 5142 | |
Jul 25, 2024 | - | - | 4204 | |
Jun 08, 2023 | - | - | 8030 | |
May 04, 2023 | - | - | 6118 |
Team profile of Atlas Accelerator
Atlas Accelerator has a team of 4 members. Atlas Accelerator's team does not sit on the board of any company as of now.Co-investors of Atlas Accelerator
Over the past 17 years, 8 investors have co-invested in Atlas Accelerator's portfolio companies. This includes funds and angels.
- Top Co-investors of Atlas Accelerator: 2 investors entered a company along with Atlas Accelerator. These include investors like Alliance of Angels (3 companies).
- Invested after Atlas Accelerator: A total of 6 investors have invested in Atlas Accelerator's portfolio after their investments. Top Investors include Keiretsu Forum (1 company) and Siemer & Associates (1 company).
